Anterogen.Co.Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Anterogen.Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Anterogen.Co.Ltd (065660) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩281.98 Million ≈ $191.09K USD) by net assets (₩90.04 Billion ≈ $61.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Anterogen.Co.Ltd (2014–2024)

Cash flow conversion efficiency of Anterogen.Co.Ltd from 2014 to 2024. This chart illustrates how Anterogen.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Anterogen.Co.Ltd share price for real-time trading data and today's change.

Anterogen.Co.Ltd Cash Flow Conversion Ratio Explained

Anterogen.Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Anterogen.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anterogen.Co.Ltd ranked by their cash flow conversion efficiency. Also see Anterogen.Co.Ltd (065660) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Real Estate & E-Commerce Split Corp TO:RS	-0.015x
Nutriband Inc NASDAQ:NTRB	-0.110x
EverFocus Electronics Corp TW:5484	-0.043x
Pioneer Credit Ltd AU:PNC	0.010x
AGFA Gevaert NV BR:AGFB	0.120x
Aniplus Inc KQ:310200	0.279x
DEVEX Resources Ltd AU:DEV	-0.147x
Tan Chong Motor Holdings Bhd KLSE:4405	0.024x

Annual Cash Flow Conversion Efficiency for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Anterogen.Co.Ltd from 2014 to 2024. Review Anterogen.Co.Ltd (065660) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩110.21 Billion ≈ $74.69 Million	₩-860.38 Million ≈ $-583.06K	-0.008x	+49.17%
2023-12-31	₩129.44 Billion ≈ $87.72 Million	₩-1.99 Billion ≈ $-1.35 Million	-0.015x	+16.96%
2022-12-31	₩106.79 Billion ≈ $72.37 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.018x	+29.02%
2021-12-31	₩116.87 Billion ≈ $79.20 Million	₩-3.05 Billion ≈ $-2.06 Million	-0.026x	+52.15%
2020-12-31	₩81.07 Billion ≈ $54.94 Million	₩-4.41 Billion ≈ $-2.99 Million	-0.054x	-125.90%
2019-12-31	₩68.39 Billion ≈ $46.35 Million	₩-1.65 Billion ≈ $-1.12 Million	-0.024x	+10.16%
2018-12-31	₩56.07 Billion ≈ $38.00 Million	₩-1.50 Billion ≈ $-1.02 Million	-0.027x	-429.83%
2017-12-31	₩46.61 Billion ≈ $31.58 Million	₩379.21 Million ≈ $256.98K	0.008x	+311.89%
2016-12-31	₩34.02 Billion ≈ $23.06 Million	₩-130.65 Million ≈ $-88.54K	-0.004x	-107.57%
2015-12-31	₩16.64 Billion ≈ $11.28 Million	₩844.49 Million ≈ $572.30K	0.051x	+165.11%
2014-12-31	₩12.96 Billion ≈ $8.78 Million	₩-1.01 Billion ≈ $-684.63K	-0.078x	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$70.45 Million

₩103.95 Billion KRW

Market Cap Rank

#20375 Global

#1108 in Korea

Share Price

₩13070.00

Change (1 day)

-3.61%

52-Week Range

₩13070.00 - ₩58000.00

All Time High

₩197700.00